{"podcast":{"title":"RealTalk MS","slug":"realtalk-ms-779631","podcast_index_feed_id":779631,"rss_url":"https://realtalkms.libsyn.com/rss","website_url":"http://www.realtalkms.com","image_url":"https://static.libsyn.com/p/assets/c/f/6/f/cf6fc1e12c2339c0/Apple_artwork.jpg","author":"Jon Strum","episode_count":517,"summary":"Jon Strum cuts through all the jargon and breaks down the latest multiple sclerosis news. You'll meet the scientists who are creating tomorrow's MS treatments today. You'll hear from the experts discussing how the latest tweaks and changes to our healthcare laws will impact your MS treatment. And we'll be talking to the courageous MS warriors who are out there advocating on behalf of the MS community every day, as well as the men and women who are committed to living their best lives with MS and living their best lives as MS caregivers. If you're dealing with multiple sclerosis in your life -- as a patient, caregiver, family member, or friend -- join us each week for RealTalk MS.","last_synced_at":"2026-07-14T10:18:55.825945+00:00","page_url":"https://stenobird.com/podcast/realtalk-ms-779631"},"episode":{"title":"Episode 444: Treating MS with a GLP-1 with Dr. Ellen Mowry","slug":"episode-444-treating-ms-with-a-glp-1-with-dr-ellen-mowry","published_at":"2026-03-02T23:00:00+00:00","page_url":"https://stenobird.com/podcast/realtalk-ms-779631/episode-444-treating-ms-with-a-glp-1-with-dr-ellen-mowry","show_page_url":"https://stenobird.com/podcast/realtalk-ms-779631","url":"https://realtalkms.com/444","audio_url":"https://traffic.libsyn.com/secure/realtalkms/Episode_444_Treating_MS_with_a_GLP-1_with_Dr._Ellen_Mowry.mp3?dest-id=570470","summary":"You know them by their trade names such as Ozempic, Wegovy, Mounjaro, and Zepbound. This class of medications is known as GLP-1 receptor agonists. And while they are best known for managing diabetes and promoting weight loss, researchers are finding that these drugs are also effective in a broad range of other health conditions. So, what about MS? My guest this week is Dr. Ellen Mowry, the principal investigator of a clinical trial to determine whether a GLP-1 drug can reduce brain inflammation and provide neuroprotection in people living with progressive MS. We're sharing details about the discovery of a new biomarker that not only confirms an MS diagnosis but also predicts the severity of an individual's disease course in the years ahead. We'll tell you about three studies focused on better managing some of the most common MS symptoms and funded by the International Progressive MS Alliance. And we'll explain how Merck and the Mayo Clinic are partnering to build a first-of-its-kind drug discovery platform using AI. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: A GLP-1 for MS? :22 I'm asking for your support: 1:31 Researchers discover biomarkers that can predict future disease course 2:13 The International Progressive MS Alliance invests $8.1 million in global studies that address the most common MS symptoms 5:44 Merck and the Mayo Clinic collaborate on AI-driven drug discovery platform 10:02 Dr. Ellen Mowry discusses the clinical trial to determine whether a GLP-1 drug can reduce inflammation in the central nervous system and offer neuroprotection to people with progressive MS 12:20 Share this episode 30:17 Next week 30:38 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/444 ADD…","meta_description":"You know them by their trade names such as Ozempic, Wegovy, Mounjaro, and Zepbound. This class of medications is known as GLP-1 receptor agonists. And whi…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1893,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/realtalk-ms-779631/episodes/episode-444-treating-ms-with-a-glp-1-with-dr-ellen-mowry/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/realtalk-ms-779631/episode-444-treating-ms-with-a-glp-1-with-dr-ellen-mowry.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}